• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Disc Medicine, Inc. - Common Stock (NQ:IRON)

74.78 +4.62 (+6.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,903,643
Open 70.21
Bid (Size) 75.55 (200)
Ask (Size) 84.00 (200)
Prev. Close 70.16
Today's Range 69.44 - 75.00
52wk Range 40.00 - 99.50
Shares Outstanding 22,877,552
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
June 15, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
June 12, 2026
From Disc Medicine Inc
Via GlobeNewswire

Performance

YTD
-5.4%
-5.4%
1 Month
+9.8%
+9.8%
3 Month
+20.6%
+20.6%
6 Month
-6.9%
-6.9%
1 Year
+38.7%
+38.7%

More News

Read More
News headline image
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
June 09, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
June 05, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
June 02, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients
June 01, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges ↗
May 26, 2026
Via MarketBeat
News headline image
Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2026 Congress
May 12, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
Disc Medicine to Participate in Upcoming Investor Conferences
May 11, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
May 07, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
May 05, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
April 28, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
April 25, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
April 21, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Disc Medicine Insider Sells $380K in Stock Amid 70% One-Year Surge ↗
April 21, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
April 21, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
April 14, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
April 07, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Disc Medicine, Inc. - IRON
March 31, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
March 27, 2026
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Disc Medicine Announces Completion of Enrollment of Phase 3 APOLLO Trial of Bitopertin in Erythropoietic Protoporphyria
March 26, 2026
From Disc Medicine Inc
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Disc Medicine, Inc. – IRON
March 24, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation – IRON
March 19, 2026
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
March 18, 2026
From Schall Law
Via GlobeNewswire
News headline image
IRON Investors Have Opportunity to Join Disc Medicine, Inc. Fraud Investigation with the Schall Law Firm
March 14, 2026
From The Schall Law Firm
Via Business Wire

Frequently Asked Questions

Is Disc Medicine, Inc. - Common Stock publicly traded?
Yes, Disc Medicine, Inc. - Common Stock is publicly traded.
What exchange does Disc Medicine, Inc. - Common Stock trade on?
Disc Medicine, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Disc Medicine, Inc. - Common Stock?
The ticker symbol for Disc Medicine, Inc. - Common Stock is IRON on the Nasdaq Stock Market
What is the current price of Disc Medicine, Inc. - Common Stock?
The current price of Disc Medicine, Inc. - Common Stock is 74.78
When was Disc Medicine, Inc. - Common Stock last traded?
The last trade of Disc Medicine, Inc. - Common Stock was at 06/26/26 04:00 PM ET
What is the market capitalization of Disc Medicine, Inc. - Common Stock?
The market capitalization of Disc Medicine, Inc. - Common Stock is 1.71B
How many shares of Disc Medicine, Inc. - Common Stock are outstanding?
Disc Medicine, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap